43 results on '"Voso, M"'
Search Results
2. P987: A DIFFERENT BALANCE IN OXIDATIVE STRESS RESPONSE IN CALR AND JAK2 MUTATED MYELOFIBROSIS PATIENTS CORRELATES WITH CLINICAL OUTCOME
3. S130: NPM1 MUTATED AML: IMPACT OF CO-MUTATIONAL PATTERNS - RESULTS OF THE EUROPEAN HARMONY ALLIANCE
4. P1000: INCREASED PLASMA LEVELS OF LNCRNAS ARE POTENTIAL PROGNOSTIC BIOMARKERS IN MYELOFIBROSIS
5. P434: MITOCONDRIAL MCL1 REGULATES LEUKEMIC CELLS METABOLISM VIA DIRECT INTERACTION WITH HEXOKINASE II. METABOLIC SIGNATURE AT ONSET PREDICTS OVERALL SURVIVAL IN AMLS’ PATIENTS
6. Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS
7. Mobilization and Selection of CD 34+ Cells
8. Function of PU.1 (Spi-1), C/EBP, and AML1 in Early Myelopoiesis: Regulation of Multiple Myeloid CSF Receptor Promoters
9. Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies
10. Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia
11. MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine
12. Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia
13. PML–RARα kinetics and impact of FLT3–ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy
14. An abnormal secretion of soluble mediators contributes to the hematopoietic-niche dysfunction in low-risk myelodysplastic syndrome
15. Fanconi anemia gene variants in therapy-related myeloid neoplasms
16. 251 TS, MTHFR AND XRCC1 GENETIC VARIANTS INFLUENCE THE OUTCOME OF MDS PATIENTS IRRESPECTIVELY OF IPSS RISK
17. SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms
18. Why methylation is not a marker predictive of response to hypomethylating agents
19. Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine
20. P-097 The revised IPSS predicts prognosis of myelodysplastic syndromes significantly better than IPSS and WPSS: Validation by the GROM database
21. Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases
22. Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-Azacytidine
23. Risk of acute promyelocytic leukemia in multiple sclerosis: Coding variants of DNA repair genes
24. Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapy
25. Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies
26. P138 Valproic acid at therapeutic plasma levels may increase 5-azacitidine efficacy in higher risk myelodysplastic syndromes
27. Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia
28. Combined Voriconazole Plus Caspofungin Therapy for the Treatment of Probable Geotrichum Pneumonia in a Leukemia Patient
29. Therapy-related leukemia and myelodysplasia: susceptibility and incidence
30. Blastoid Mantle Cell Lymphoma Occurring in a Patient in Complete Remission of Chronic Myelogenous Leukemia
31. Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia
32. Treatment of Acute Leukaemias with Monoclonal Antibodies: Current Status and Future Prospects
33. High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors
34. Prevalence of Mutated Factor V ARG506 to GLN in Italians
35. The Growth of Primary Low-Grade B-Cell Gastric Lymphoma Is Sustained byHelicobacter pylori
36. HIGH‐DOSE THERAPY WITH PERIPHERAL BLOOD STEM CELL TRANSPLANTATION RESULTS IN A SIGNIFICANT REDUCTION OF THE HaEMOPOIETIC PROGENITOR CELL COMPARTMENT
37. Inhibition of hematopoiesis by competitive binding of transcription factor PU.1.
38. DISAPPEARANCE OF SPONTANEOUS ERYTHROID COLONIES IN PATIENTS WITH MYELOPROLIFERATIVE DISORDERS TREATED BY ALPHA‐INTERFERON
39. Behaviour of transition-metal disulphides as intercalation electrodes in solid-state cells
40. A Cyclable Copper Solid‐State Cell Based on Intercalation Electrodes
41. ChemInform Abstract: INTERCALATION OF SILVER AND COPPER IN TITANIUM DISULPHIDE FROM SOLID-STATE CELLS
42. Spontaneous polymerization of methyl methacrylate in aqueous sulfuric acid
43. ChemInform Abstract: A (RECHARGEABLE) COPPER SOLID-STATE CELL BASED ON INTERCALATION ELECTRODES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.